Search results for "From ACP Internist"

Results 21 - 30 of about 69 for "From ACP Internist".
Sort by: Relevance | Newest | Oldest

SGLT-2 inhibitors not associated with increased risk for severe UTIs

An accompanying editorial said that while the study's finding is reassuring, it should be considered with caution, especially since high-risk patients and those with previous urinary tract infections (UTIs) were excluded.
9 Aug 2019

Group-based lifestyle intervention reduced risk of type 2 diabetes

Participants in the Norfolk Diabetes Prevention Study who underwent multiple educational group sessions that included 50-minute sessions of supervised physical activity had significantly lower odds of type 2 diabetes during a mean follow-up of two years compared to those who received usual care.
13 Nov 2020

Type of insulin may affect hypoglycemia rates in older adults with type 2 diabetes, study finds

The risk of hospital visits for hypoglycemia was lower with long-acting insulin analogs versus neutral protamine Hagedorn (NPH) insulin in a retrospective study of Medicare patients.
12 Mar 2021

Once-weekly insulin had similar effects to daily insulin in type 2 diabetes, industry-funded trial finds

HbA1c levels improved by more than a point in insulin-naive patients with inadequately controlled type 2 diabetes who were randomized to a weekly 70-U dose of an investigational insulin.
9 Oct 2020

Prediabetes and artificial pancreas devices

The July/August issue of ACP Internist includes articles on prediabetes and next-generation insulin pumps.
14 Jul 2017

CGM decreased HbA1c levels, hypoglycemia in patients with type 2 diabetes

Two industry-supported studies of continuous glucose monitoring (CGM) found encouraging results in patients with type 2 diabetes, leading editorialists to call for broadened access to the technology in this population, particularly in primary care.
11 Jun 2021

Reconciling conflicting diabetes guidance

ACP Internist discusses disagreement among professional medical societies on appropriate glycemic control goals following ACP's recent guidance recommending a higher target HbA1c.
8 Jun 2018

SGLT-2 inhibitors associated with lower risk of gout vs. GLP-1 receptor agonists

In a large, propensity-matched study, adult patients with type 2 diabetes who were newly prescribed a sodium-glucose cotransporter-2 (SGLT-2) inhibitor had a lower rate of incident gout than those newly prescribed a glucagon-like peptide-1 (GLP-1) receptor agonist.
14 Feb 2020

Diabetes remission through diet may be doable, with support

An article in the May ACP Internist discusses how intensive lifestyle interventions may be able to send type 2 diabetes into remission for selected patients.
11 May 2018

System-wide changes improve diabetes care

A Success Story in the latest issue of ACP Internist describes a primary care intervention to improve HbA1c testing.
16 Sep 2016

Result Page: Prev   1   2   3   4   5   6   7   Next